Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gloria P Lipori"'
Autor:
Dominick J Lemas, Jasmine A Mack, Jennifer J Schoch, Nicole Cacho, Elizabeth Plasencia, Alice S Rhoton-Vlasak, Josef Neu, Lindsay Thompson, Magda Francois, Keval Patel, William R Hogan, Gloria P Lipori, Matthew J Gurka
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229861 (2020)
BackgroundDelivery by cesarean section (C-section) is associated with adverse short-term and long-term infant outcomes. Given that antibiotics during early life are prescribed for infant outcomes that are more likely among c-section deliveries, we hy
Externí odkaz:
https://doaj.org/article/d688751291ac4db5a4015b10b8065d9e
Autor:
Nida Waheed, Michael G. Fradley, David DeRemer, Ahmad Mahmoud, Chintan P. Shah, Taimour Y. Langaee, Gloria P. Lipori, Keith March, Carl J. Pepine, Rhonda M. Cooper-DeHoff, Yonghui Wu, Yan Gong
Background: Immune checkpoint inhibitors (ICIs) are a novel class of anticancer agents that have demonstrated clinical response for both solid and hematological malignancies. ICIs are associated with development of immune-related adverse events inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc90fc8b6656b7648722457b15d2b238
https://doi.org/10.21203/rs.3.rs-50662/v3
https://doi.org/10.21203/rs.3.rs-50662/v3
Autor:
Nida Waheed, Michael G. Fradley, David L. DeRemer, Ahmad Mahmoud, Chintan P. Shah, Taimour Y. Langaee, Gloria P. Lipori, Keith March, Carl J. Pepine, Rhonda M. Cooper-DeHoff, Yonghui Wu, Yan Gong
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Immune checkpoint inhibitors (ICIs) are a novel class of anticancer agents that have demonstrated clinical response for both solid and hematological malignancies. ICIs are associated with development of immune-related adverse even
Externí odkaz:
https://doaj.org/article/eb7e60208f7745ba8dc1a5a95738d23d